We report a rare case of Takayasu's arteritis with isolated pulmonary artery stenosis in the presence of active hepatitis B and latent Mycobacterium tuberculosis infection in a middle-aged Asian woman who initially presented with severe dyspnea on exertion and recurrent syncope, occasional burning chest pains, and fatigue. Therapy of the active hepatitis B and latent M. tuberculosis infection together with a course of methotrexate led to a slight reversal of the symptoms, as angioplasty with or without stenting was not an option. The constellation described here hints at the possible link between hepatitis B and M. tuberculosis infection and the development of Takayasu's arteritis. The case also supports the little evidence available indicating that treatment of active hepatitis B infection could positively influence the course of Takayasu's arteritis.

Keywords:
Takayasu’s arteritis, Vasculitis, Radiographic diagnosis, Pulmonary artery stenosis, Isolated pulmonary artery stenosis
1.
Arnaud L, Haroche J, Mathian A, et al: Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev 2011;11:61-67.
2.
Jennette JC, Falk RJ, Bacon PA, et al: 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
3.
Toledano K, Guralnik L, Lorber A, et al: Pulmonary arteries involvement in Takayasu's arteritis: two cases and literature review. Semin Arthritis Rheum 2011;41:461-470.
4.
Fukuda Y, Shirai K, Takamiya Y, et al: Isolated pulmonary arterial stenosis caused by Takayasu's arteritis in an elderly male. J Cardiol 2008;51:196-200.
5.
Korkmaz C, Zubaroglu I, Kaya T, et al: Takayasu's arteritis associated with rheumatoid arthritis: a case report and review of the literature. Rheumatology (Oxford) 2001;40:1420-1422.
6.
Lupi-Herrera E, Sánches-Torres G, Marcushamer J, et al: Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 1977;93:94-103.
7.
Karadag O, Aksu K, Sahin A, et al: Assessment of latent tuberculosis infection in Takayasu arteritis with tuberculin skin test and Quantiferon-TB Gold test. Rheumatol Int 2010;30:1483-1487.
8.
Mwipatayi BP, Jeffery PC, Beningfield SJ, et al: Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 2005;75:110-117.
9.
Kumar Chauhan S, Kumar Tripathy N, Sinha N, et al: Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis. Clin Exp Immunol 2004;138:547-553.
10.
Soto ME, Del Carmen Ávila-Casado M, Huesca-Gómez C, et al: Detection of IS6110 and HupB gene sequences of Mycobacterium tuberculosis and bovis in the aortic tissue of patients with Takayasu's arteritis. BMC Infect Dis 2012;12:1-14.
11.
Castillo-Martínez D, Amezcua-Guerra LM: Self-reactivity against stress-induced cell molecules: the missing link between Takayasu's arteritis and tuberculosis? Med Hypotheses 2012;78:485-488.
12.
Ozenirler S, Gokalp-Yasar D, Demirag M, et al: Takayasu's arthritis associated with chronic hepatitis B. Acta Gastroenterol Belg 2007;70:306-307.
13.
Zaas A, Scheel P, Venbrux A, et al: Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases. J Rheumatol 2001;28:1116-1120.
14.
Prokhorova MV, Zverev KV, Krel PE: Takayasu's disease associated with liver cirrhosis in a patient with HBs-antigenemia (in Russian). Ter Arkh 1992;64:103-104.
15.
Castresana-Isla CJ, Herrera-Martinez G, Vega-Molina J: Erythema nodosum and Takayasu's arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol 1993;20:1417-1418.
16.
Finsterer J: Systemic and non-systemic vasculitis affecting the peripheral nerves. Acta Neurol Belg 2009;109:100-113.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.